Pfizer
Could Mix It Up
The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.
Vaccine Authorization for Kids Sought
Pfizer and BioNTech are seeking emergency regulatory authorization for their SARS-CoV-2 vaccine for kids, the New York Times says.
US Booster Eligibility Decision
The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.
Booster for At-Risk
The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.
Hundreds of Millions More to Share
The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.